Arohan Struggles in Q2FY26 with Weak Growth and Rising Credit Stress

Arohan Struggles in Q2FY26 with Weak Growth and Rising Credit Stress
Lovely Baghel
Author

Lovely Baghel

Executive Digital Marketer

Digital Marketer

Publish Date22 November 2025
Reading time2 Min

Share on Social Links

Category

StockBeginner GuideAngel InvestingSME IPOEconomy MarketAIFInvestmentsMore
  • Financial Performance (Q2FY26 vs Q2FY25): In Q2 FY26 Arohan Financial reported total revenue of ₹381 crore, down 16.4% YoY from ₹456 crore in Q2 FY25. Interest income fell to ₹342 crore, down 19.4% YoY from ₹424 crore, while fees and other non-interest income also moderated. Finance costs declined to ₹128 crore, down 23.6% YoY, offering some relief, but impairment on financial instruments remained elevated at ₹95 crore (down 4.2% YoY). Profit before tax (PBT) came in at ₹26 crore, down 56.6% YoY from ₹59 crore, and profit after tax (PAT) was ₹20 crore, down 56.2% YoY from ₹45 crore. Basic EPS for the quarter fell to ₹1.28 from ₹2.93 a year earlier (down 56.3%).
  • Operational Metrics (Q2FY26 vs Q2FY25): Gross Stage-3 (GNPA) ratio was 2.0%, up from ~1.5% a year ago, and Net Stage-3 (NNPA) ratio was 0.52% (vs 0%), indicating a deterioration in asset quality. Provision Coverage Ratio (PCR) stood at 74.5%, lower than earlier peak levels but still providing a material cushion. Capital adequacy remained strong at 34.5%. Loan book (loans on balance sheet) was ₹5,622 crore as at Sept 30, 2025, marginally down 1.5% versus Mar 31, 2025 (₹5,705 crore), while total assets rose to ₹7,117 crore (up 3.3% vs Mar 31, 2025). Net worth was ₹2,054 crore, up 1.4% sequentially. 
  • Strategic Developments: Arohan’s Q2 results show weaker revenue and sharply lower profitability driven by sustained credit costs and softer interest/fee income. The moderation in finance costs helps, but elevated impairments keep returns depressed. The slightly higher GNPA and lower PCR versus prior peaks mean asset-quality improvement must be watched closely. On the positive side, the company’s capital adequacy is strong and total assets are steady; with RBI’s earlier lifting of lending restrictions, Arohan can normalize disbursements — this should support loan-book recovery and revenue traction over coming quarters, provided underwriting and collections are tightened and operating costs are managed.

Tags

Unlisted SharesPre-IPOInvestmentStock MarketFinance

Stay Connected, Stay Informed –

Join Our

WhatsApp

Channel!

Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.